PL2902787T3 - Sposób oceny reakcji krzepnięcia krwi - Google Patents
Sposób oceny reakcji krzepnięcia krwiInfo
- Publication number
- PL2902787T3 PL2902787T3 PL13842222T PL13842222T PL2902787T3 PL 2902787 T3 PL2902787 T3 PL 2902787T3 PL 13842222 T PL13842222 T PL 13842222T PL 13842222 T PL13842222 T PL 13842222T PL 2902787 T3 PL2902787 T3 PL 2902787T3
- Authority
- PL
- Poland
- Prior art keywords
- blood coagulation
- coagulation reaction
- evaluating blood
- evaluating
- reaction
- Prior art date
Links
- 230000023555 blood coagulation Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6443—Coagulation factor XIa (3.4.21.27)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/745—Assays involving non-enzymic blood coagulation factors
- G01N2333/755—Factors VIII, e.g. factor VIII C [AHF], factor VIII Ag [VWF]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96433—Serine endopeptidases (3.4.21)
- G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
- G01N2333/96452—Factor XI (3.4.21.27)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/22—Haematology
- G01N2800/224—Haemostasis or coagulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012217925 | 2012-09-28 | ||
| EP13842222.5A EP2902787B1 (en) | 2012-09-28 | 2013-09-26 | Method for evaluating blood coagulation reaction |
| PCT/JP2013/075978 WO2014050926A1 (ja) | 2012-09-28 | 2013-09-26 | 血液凝固反応の評価方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2902787T3 true PL2902787T3 (pl) | 2018-08-31 |
Family
ID=50388321
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13842222T PL2902787T3 (pl) | 2012-09-28 | 2013-09-26 | Sposób oceny reakcji krzepnięcia krwi |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11078518B2 (https=) |
| EP (1) | EP2902787B1 (https=) |
| JP (1) | JP6284481B2 (https=) |
| KR (1) | KR102134305B1 (https=) |
| CN (1) | CN104937423B (https=) |
| BR (1) | BR112015006634B1 (https=) |
| CA (1) | CA2886326C (https=) |
| ES (1) | ES2668455T3 (https=) |
| MX (1) | MX358997B (https=) |
| PL (1) | PL2902787T3 (https=) |
| RU (1) | RU2683933C2 (https=) |
| TW (1) | TWI609083B (https=) |
| WO (1) | WO2014050926A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI452136B (zh) | 2010-11-17 | 2014-09-11 | 中外製藥股份有限公司 | A multiple specific antigen-binding molecule that replaces the function of Factor VIII in blood coagulation |
| TWI700300B (zh) | 2014-09-26 | 2020-08-01 | 日商中外製藥股份有限公司 | 中和具有第ｖｉｉｉ凝血因子（ｆｖｉｉｉ）機能替代活性的物質之抗體 |
| TWI701435B (zh) | 2014-09-26 | 2020-08-11 | 日商中外製藥股份有限公司 | 測定ｆｖｉｉｉ的反應性之方法 |
| CN107533071A (zh) | 2015-04-24 | 2018-01-02 | 公立大学法人奈良县立医科大学 | 血液受试体的凝固能力的评价方法、以及用于在该方法中使用的试剂、试剂盒及装置 |
| CR20180554A (es) | 2016-04-28 | 2019-01-10 | Chugai Pharmaceutical Co Ltd | Preparaciones que contienen anticuerpos |
| JP7101351B2 (ja) * | 2016-04-28 | 2022-07-15 | シスメックス株式会社 | 血液検体の分析方法、血液検体分析用試薬及び試薬キット、並びに血液検体分析装置 |
| CN110461358A (zh) | 2017-03-31 | 2019-11-15 | 公立大学法人奈良县立医科大学 | 可用于预防和/或治疗凝血因子ⅸ异常、包含代替凝血因子ⅷ的功能的多特异性抗原结合分子的药物组合物 |
| CN119161488A (zh) | 2017-11-01 | 2024-12-20 | 中外制药株式会社 | 具有降低的生物活性的抗体变体和同种型 |
| RU2699798C1 (ru) * | 2019-05-22 | 2019-09-11 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр гематологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ гематологии" Минздрава России) | Способ выявления дефицитов факторов свертывания крови методом тромбоэластометрии |
| JP6883899B1 (ja) * | 2020-12-07 | 2021-06-09 | 株式会社血栓トランスレーショナルリサーチラボ | 血液凝固検査試薬、および血液凝固検査方法 |
| US12588235B2 (en) | 2022-01-27 | 2026-03-24 | Vanguard International Semiconductor Corporation | Semiconductor structure and manufacturing method of the same |
| WO2024143525A1 (ja) | 2022-12-28 | 2024-07-04 | 積水メディカル株式会社 | 血液検体の血液凝固能の分析方法 |
| WO2024143524A1 (ja) | 2022-12-28 | 2024-07-04 | 積水メディカル株式会社 | 血液検体の血液凝固能の分析方法 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| JP2746386B2 (ja) * | 1988-09-07 | 1998-05-06 | 清水製薬株式会社 | 全血を用いた血液凝固能検査法 |
| DK162233C (da) * | 1989-11-09 | 1992-03-16 | Novo Nordisk As | Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii |
| WO1996033735A1 (en) | 1995-04-27 | 1996-10-31 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| ATE158021T1 (de) | 1990-08-29 | 1997-09-15 | Genpharm Int | Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper |
| WO1993012227A1 (en) | 1991-12-17 | 1993-06-24 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| DK0638127T3 (da) * | 1992-04-27 | 2000-12-18 | Avocet Medical Inc | Testartikel og fremgangsmåde til at udføre blodkoagulationsanalyser |
| ES2301158T3 (es) | 1992-07-24 | 2008-06-16 | Amgen Fremont Inc. | Produccion de anticuerpos xenogenicos. |
| JPH08509612A (ja) | 1993-04-26 | 1996-10-15 | ジェンファーム インターナショナル インコーポレイテッド | 異種抗体を産生することができるトランスジェニック非ヒト動物 |
| FR2707189B1 (fr) | 1993-07-09 | 1995-10-13 | Gradient Ass | Procédé de traitement de résidus de combustion et installation de mise en Óoeuvre dudit procédé. |
| DE69535243T2 (de) | 1994-07-13 | 2007-05-10 | Chugai Seiyaku K.K. | Gegen menschliches interleukin-8 gerichteter, rekonstituierter menschlicher antikörper |
| WO1996034096A1 (en) | 1995-04-28 | 1996-10-31 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| AT405692B (de) * | 1997-03-27 | 1999-10-25 | Immuno Ag | Reagens zur bestimmung der aptt |
| DK1069185T3 (da) | 1998-04-03 | 2011-06-27 | Chugai Pharmaceutical Co Ltd | Humaniseret antistof mod human vævsfaktor (TF) og fremgangsmåde til at konstruere humaniseret antistof |
| EP1332209B1 (en) | 2000-09-08 | 2009-11-11 | Universität Zürich | Collections of repeat proteins comprising repeat modules |
| EP2141243A3 (en) | 2000-10-16 | 2010-01-27 | Brystol-Myers Squibb Company | Protein scaffolds for antibody mimics and other binding proteins |
| US20030157561A1 (en) | 2001-11-19 | 2003-08-21 | Kolkman Joost A. | Combinatorial libraries of monomer domains |
| US7297336B2 (en) * | 2003-09-12 | 2007-11-20 | Baxter International Inc. | Factor IXa specific antibodies displaying factor VIIIa like activity |
| WO2005035753A1 (ja) | 2003-10-10 | 2005-04-21 | Chugai Seiyaku Kabushiki Kaisha | 機能蛋白質を代替する二重特異性抗体 |
| US20050164301A1 (en) | 2003-10-24 | 2005-07-28 | Avidia Research Institute | LDL receptor class A and EGF domain monomers and multimers |
| DE102005008066A1 (de) * | 2005-02-22 | 2006-08-24 | Haemosys Gmbh | Verfahren zur Bestimmung der Gesamtgerinnungsaktivität einer Blut- oder Plasmaprobe |
| PT1876236E (pt) * | 2005-04-08 | 2014-10-22 | Chugai Pharmaceutical Co Ltd | Anticorpos para substituição da função do factor de coagulação sanguínea viii |
| CN101415445A (zh) * | 2006-03-31 | 2009-04-22 | 巴克斯特国际公司 | 聚乙二醇化的因子ⅷ |
| AU2007245190B2 (en) | 2006-03-31 | 2011-07-21 | Takeda Pharmaceutical Company Limited | Pegylated factor VIII |
| TWI452136B (zh) * | 2010-11-17 | 2014-09-11 | 中外製藥股份有限公司 | A multiple specific antigen-binding molecule that replaces the function of Factor VIII in blood coagulation |
| US20140296146A1 (en) | 2011-08-23 | 2014-10-02 | Synapse B.V. | Thermostable Inhibitors of Activation of the Blood Clotting System Through Contact with Foreign Surfaces |
-
2013
- 2013-09-26 BR BR112015006634-8A patent/BR112015006634B1/pt active IP Right Grant
- 2013-09-26 EP EP13842222.5A patent/EP2902787B1/en active Active
- 2013-09-26 TW TW102134691A patent/TWI609083B/zh active
- 2013-09-26 RU RU2015115277A patent/RU2683933C2/ru active
- 2013-09-26 JP JP2014538571A patent/JP6284481B2/ja active Active
- 2013-09-26 US US14/431,425 patent/US11078518B2/en active Active
- 2013-09-26 PL PL13842222T patent/PL2902787T3/pl unknown
- 2013-09-26 CA CA2886326A patent/CA2886326C/en active Active
- 2013-09-26 WO PCT/JP2013/075978 patent/WO2014050926A1/ja not_active Ceased
- 2013-09-26 MX MX2015003740A patent/MX358997B/es active IP Right Grant
- 2013-09-26 KR KR1020157010558A patent/KR102134305B1/ko active Active
- 2013-09-26 ES ES13842222.5T patent/ES2668455T3/es active Active
- 2013-09-26 CN CN201380061538.7A patent/CN104937423B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2886326C (en) | 2021-11-02 |
| TWI609083B (zh) | 2017-12-21 |
| BR112015006634B1 (pt) | 2022-06-14 |
| EP2902787B1 (en) | 2018-03-28 |
| US11078518B2 (en) | 2021-08-03 |
| HK1212443A1 (en) | 2016-06-10 |
| CA2886326A1 (en) | 2014-04-03 |
| CN104937423A (zh) | 2015-09-23 |
| KR102134305B1 (ko) | 2020-07-15 |
| MX2015003740A (es) | 2015-09-23 |
| WO2014050926A1 (ja) | 2014-04-03 |
| MX358997B (es) | 2018-09-12 |
| BR112015006634A2 (https=) | 2017-09-05 |
| RU2683933C2 (ru) | 2019-04-03 |
| CN104937423B (zh) | 2017-05-24 |
| KR20150068406A (ko) | 2015-06-19 |
| TW201418470A (zh) | 2014-05-16 |
| EP2902787A4 (en) | 2016-03-23 |
| EP2902787A1 (en) | 2015-08-05 |
| US20150240287A1 (en) | 2015-08-27 |
| JPWO2014050926A1 (ja) | 2016-08-22 |
| JP6284481B2 (ja) | 2018-02-28 |
| ES2668455T3 (es) | 2018-05-18 |
| RU2015115277A (ru) | 2016-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2902787T3 (pl) | Sposób oceny reakcji krzepnięcia krwi | |
| SG10201704633UA (en) | Methods for targeted genomic analysis | |
| ZA201501833B (en) | Method for obtaining 1-kestone | |
| LT3305918T (lt) | Būdai, skirti epigenetinių sekų sudarymui | |
| GB201217772D0 (en) | Sequencing method | |
| EP2768983A4 (en) | METHODS OF IDENTIFYING MUTATIONS ASSOCIATED WITH DISEASES | |
| GB2518081B (en) | Providing an ID-verified blood test | |
| PL2936124T3 (pl) | Sposoby oceniania medycznych krzywych pomiarowych | |
| HUP1200607A2 (en) | Diagnostic method | |
| GB201100282D0 (en) | Biological methods | |
| EP2685257A4 (en) | METHOD OF ANALYSIS | |
| EP2833140A4 (en) | PROCESS FOR DETECTING BIOLOGICAL MATERIALX | |
| GB201011420D0 (en) | Method for diagnosis | |
| GB201218341D0 (en) | Diagnostic method | |
| SG10201703766TA (en) | Methods for processing biomass-derived feedstocks | |
| EP2803738A4 (en) | METHOD FOR OPERATING A FLASHING BALLOON | |
| AP2013007084A0 (en) | Diagnostic method | |
| GB201100223D0 (en) | Diagnostic method | |
| GB2517113B (en) | Method involving pre-treating medical instruments | |
| GB201000532D0 (en) | Method for monitoring of blood components | |
| SG11201405308XA (en) | Sterilization method | |
| GB201204071D0 (en) | Polymer treatment method | |
| GB201004226D0 (en) | Process analysis | |
| EP2803730A4 (en) | PROCESS FOR PREPARING A CHEMICAL SUBSTANCE | |
| EP2753706A4 (en) | METHODS OF TREATING COAGULATION FACTORS |